Artificial Ventilation and Anesthesia Masks Market Report

Artificial Ventilation and Anesthesia Masks Market Analysis by Application (Operation Room, Intensive Care Units, Emergency Room, Dental, Home Care) by Risk of the Procedure (High, Moderate Risk, Standard Patients) and Segment Forecasts To 2022

  • Report ID: 978-1-68038-709-4
  • Number of Pages: 107
  • Format: Electronic (PDF)

Table of Content

Chapter 1 Methodology and Scope
                  1.1 Research Methodology
                  1.2 Research Scope & Assumptions
                  1.3 List of Data Sources
Chapter 2 Artificial Ventilation and Anesthesia Masks Industry Outlook
                  2.1 Market segmentation
                  2.2 Artificial ventilation and anesthesia masks market dynamics
                  2.3 Market driver analysis
                     2.3.1 Rising prevalence of respiratory disorders
                     2.3.2 Growing prevalence of sleep apnea
                     2.3.3 Increasing prevalence of sleep apnea in co-morbidities
                     2.3.4 Increasing geriatric population
                  2.4 Market restraint analysis
                  2.5 Lack of Patient Compliance
                  2.6 Key Opportunities Prioritized
                  2.7 Industry analysis – Porter’s
                  2.8 Artificial ventilation and anesthesia masks market PESTEL Analysis
                  2.9 Opportunity Analysis
                  2.10 Company market share analysis, 2014
Chapter 3 Application Outlook
                  3.1 Artificial ventilation and anesthesia masks market share by application, 2014 & 2022
                  3.2 Operation Room
                     3.2.1 Operation room market estimates and forecasts, 2012-2022
                  3.3 Intensive Care Units
                     3.3.1 Intensive care unit market estimates and forecasts, 2012-2022
                  3.4 Emergency Room
                     3.4.1 Emergency room market estimates and forecasts, 2012-2022
                  3.5 Dental
                     3.5.1 Dental market estimates and forecasts, 2012-2022
                  3.6 Home Care
                     3.6.1 Homecare market estimates and forecasts, 2012-2022
Chapter 4 Artificial Ventilation and Anesthesia Masks Regional Outlook
                  4.1 Artificial ventilation and anesthesia masks market share, by region, 2014 & 2022
                  4.2 North America
                     4.2.1 North America artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022 (USD Million)
                     4.2.2 North America artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.2.3 North America artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.3 U.S.
                     4.3.1 Number of registered hospitals in the U.S.
                     4.3.2 Total number of in-patient surgeries in the U.S., 2010.
                     4.3.3 U.S. artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.3.4 U.S. artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.3.5 U.S. artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.4 Canada
                     4.4.1 Canada top five reasons for in-patient hospitalization, 2012-2013
                     4.4.2 Top five reasons for in-patient surgeries in Canada, 2012-2013
                     4.4.3 Canada artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.4.4 Canada artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.4.5 Europe artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.5 Europe
                     4.5.1 Europe artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.5.2 Europe artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.5.3 Europe artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.6 Germany
                     4.6.1 Germany artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.6.2 Germany artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.6.3 Germany artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.7 UK
                     4.7.1 UK artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.7.2 UK artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.7.3 UK artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.8 Asia Pacific
                     4.8.1 Asia Pacific artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.8.2 Asia Pacific artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.8.3 Asia Pacific artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.9 China
                     4.9.1 China artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.9.2 China artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.9.3 China artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.10 India
                     4.10.1 India artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.10.2 India artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.10.3 India artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.11 RoW
                     4.11.1 RoW artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.11.2 RoW artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.11.3 RoW artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.12 Brazil
                     4.12.1 Brazil artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.12.2 Brazil artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.12.3 Brazil artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
                  4.8 South Africa
                     4.13.1 South Africa artificial ventilation and anesthesia masks market estimates and forecasts, high-risk procedures, 2012 – 2022(USD Million)
                     4.13.2 South Africa artificial ventilation and anesthesia masks market estimates and forecasts, moderate risk procedures, 2012 – 2022(USD Million)
                     4.13.3 South Africa artificial ventilation and anesthesia masks market estimates and forecasts, standard patients, 2012 – 2022(USD Million)
Chapter 5 Competitive Landscape
                  5.1 CareFusion
                     5.1.1 Company Overview
                     5.1.2 Financial Performance
                     5.1.3 Product Benchmarking
                     5.1.4 Strategic Initiatives
                  5.2 Air Liquide Healthcare
                     5.2.1 Company Overview
                     5.2.2 Financial Performance
                     5.2.3 Product Benchmarking
                     5.2.4 Strategic Initiatives
                  5.3 Fisher & Paykel Healthcare
                     5.3.1 Company Overview
                     5.3.2 Financial Performance
                     5.3.3 Product Benchmarking
                     5.3.4 Strategic Initiatives
                     5.3.5 ASPs, 2014
                  5.4 HOFFRICHTER GmbH
                     5.4.1 Company Overview
                     5.4.2 Financial Performance
                     5.4.3 Product Benchmarking
                     5.4.4 Strategic Initiatives
                  5.5 Drager
                     5.5.1 Company Overview
                     5.5.2 Financial Performance
                     5.5.3 Product Benchmarking
                     5.5.4 Strategic Initiatives
                  5.6 Phillips
                     5.6.1 Company Overview
                     5.6.2 Financial Performance
                     5.6.3 Product Benchmarking
                     5.6.4 Strategic Initiatives
                     5.6.5 ASPs, 2014
                  5.7 ResMed
                     5.7.1 Company Overview
                     5.7.2 Financial Performance
                     5.7.3 Product Benchmarking
                     5.7.4 Strategic Initiatives
                     5.7.5 ASPs, 2014
                  5.8 Ambu
                     5.8.1 Company Overview
                     5.8.2 Financial Performance
                     5.8.3 Product Benchmarking
                     5.8.4 Strategic Initiatives
                  5.9 Acutronic Medical Systems
                     5.9.1 Company Overview
                     5.9.2 Financial Performance
                     5.9.3 Product Benchmarking
                     5.9.4 Strategic Initiatives
                  5.10 GaleMed
                     5.10.1 Company Overview
                     5.10.2 Financial Performance
                     5.10.3 Product Benchmarking
                     5.10.4 Strategic Initiatives


List of Tables

TABLE 1 Artificial ventilation and anesthesia masks market - Industry Summary & Key Buying Criteria, 2012 - 2022
TABLE 2 Global artificial ventilation and anesthesia masks market, by application, for high risk procedures, 2012 - 2022 (USD Million)
TABLE 3 Global artificial ventilation and anesthesia masks market, by application, for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 4 Global artificial ventilation and anesthesia masks market, by application, for standard patients, 2012 - 2022 (USD Million)
TABLE 5 Artificial ventilation and anesthesia masks market, by region, for high risk procedures, 2012 - 2022 (USD Million)
TABLE 6 Artificial ventilation and anesthesia masks market, by region, for high risk procedures, 2012 - 2022 (USD Million)
TABLE 7 Artificial ventilation and anesthesia masks market, by region, for high risk procedures, 2012 - 2022 (USD Million)
TABLE 8 Market size and growth prospects, for high risk procedures, 2012 - 2022
TABLE 9 Market size and growth prospects, for moderate risk procedure, 2012 - 2022
TABLE 10 Market size and growth prospects, standard patients, 2012 - 2022
TABLE 11 Artificial ventilation and anesthesia masks market - Key market driver analysis
TABLE 12 North America geriatric population (Over 60 Years) (Million) (2012-2022)
TABLE 13 Europe geriatric population (Over 60 Years) (Million) (2012-2022)
TABLE 14 Asia geriatric population (Over 60 Years) (Million) (2012-2022)
TABLE 15 Latin America geriatric population (Over 60 Years) (Million) (2012-2022)
TABLE 16 Africa geriatric population (Over 60 Years)(Million) (2012-2022)
TABLE 17 Artificial ventilation and anesthesia masks market - Key market restraint analysis
TABLE 18 Common conditions and procedures with the highest proportion of intensive care (ICU) utilization in 29 states, 2011.
TABLE 19 North America artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 20 North America artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 21 North America artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 22 U.S. artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 23 U.S. artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 24 U.S. artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 25 Canada artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 26 Canada artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)n
TABLE 27 Canada artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 28 Europe artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 29 Europe artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 30 Europe artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 31 Germany artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 32 Germany artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 33 Germany artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 34 UK artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 35 UK artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 36 UK artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 37 Asia Pacific artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 38 Asia Pacific artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 39 Asia Pacific artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 40 China artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 41 China artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 42 China artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 43 India artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 44 India artificial ventilation and anesthesia masks for moderate risk procedures, 2012-2022, USD Million
TABLE 45 India artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 46 RoW artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 47 RoW artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 48 RoW artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 49 Brazil artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 50 Brazil artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 51 Brazil artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)
TABLE 52 South Africa artificial ventilation and anesthesia masks for high risk procedures, 2012 - 2022 (USD Million)
TABLE 53 South Africa artificial ventilation and anesthesia masks for moderate risk procedures, 2012 - 2022 (USD Million)
TABLE 54 South Africa artificial ventilation and anesthesia masks for standard risk procedures, 2012 - 2022 (USD Million)


List of Figures

FIG. 1 Artificial ventilation and anesthesia masks market segmentation
FIG. 2 Global artificial ventilation and anesthesia masks market, for high-risk procedures, 2012 - 2022 (USD Million)
FIG. 3 Global artificial ventilation and anesthesia masks market, for moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 4 Global artificial ventilation and anesthesia masks market, standard patients, 2012 - 2022 (USD Million)
FIG. 5 Artificial ventilation and anesthesia masks market dynamics
FIG. 6 Prevalence of chronic respiratory diseases globally
FIG. 7 Prevalence of sleep apnea in co-morbidities (%)
FIG. 8 Global geriatric population, 2012 - 2022 (Million)
FIG. 9 Key Opportunities Prioritized- High Risk Procedures
FIG. 10 Key Opportunities Prioritized- Moderate Risk Procedures
FIG. 11 Key Opportunities Prioritized- Standard Patients
FIG. 12 Artificial ventilation and anesthesia masks market - Porter’s analysis
FIG. 13 Artificial ventilation and anesthesia masks market PESTEL analysis
FIG. 14 Artificial ventilation masks market share analysis, 2014
FIG. 15 Artificial ventilation and anesthesia masks market share, by application, for high-risk procedures, 2014 & 2022
FIG. 16 Artificial ventilation and anesthesia masks market share, by application, for moderate risk procedures, 2014 & 2022
FIG. 17 Artificial ventilation and anesthesia masks market share, by application, for standard patients, 2014 & 2022
FIG. 18 Operation room artificial ventilation and anesthesia masks market, for high-risk procedures, 2012 - 2022 (USD Million)
FIG. 19 Operation room artificial ventilation and anesthesia masks market, for moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 20 Operation room artificial ventilation and anesthesia masks market, for standard patients, 2012 - 2022 (USD Million)
FIG. 21 Intensive care unit artificial ventilation and anesthesia masks market, for high-risk procedures, 2012 - 2022 (USD Million)
FIG. 22 Intensive care unit ventilation and anesthesia masks market, for moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 23 Intensive care unit artificial ventilation and anesthesia masks market, for standard patients, 2012 - 2022 (USD Million)
FIG. 24 Emergency room artificial ventilation and anesthesia masks market, for high-risk procedures, 2012 - 2022 (USD Million)
FIG. 25 Emergency room ventilation and anesthesia masks market, for moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 26 Emergency room artificial ventilation and anesthesia masks market, for standard patients, 2012 - 2022 (USD Million)
FIG. 27 Dental artificial ventilation and anesthesia masks market, for high-risk procedures, 2012 - 2022 (USD Million)
FIG. 28 Dental ventilation and anesthesia masks market, for moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 29 Dental artificial ventilation and anesthesia masks market, for standard patients, 2012 - 2022 (USD Million)
FIG. 30 Home care ventilation and anesthesia masks market, for standard patients, 2012 - 2022 (USD Million)
FIG. 31 Artificial ventilation and anesthesia masks market share, by region, for high-risk procedures, 2014 & 2022
FIG. 32 Artificial ventilation and anesthesia masks market share, by region, for moderate risk procedures, 2014 & 2022
FIG. 33 Artificial ventilation and anesthesia masks market share, by region, for standard patients, 2014 & 2022
FIG. 34 North America artificial ventilation and anesthesia masks market, high-risk procedures, 2012 - 2022 (USD Million)
FIG. 35 North America artificial ventilation and anesthesia masks market, moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 36 North America artificial ventilation and anesthesia masks market, standard patient, 2012 - 2022 (USD Million)
FIG. 37 Number of registered hospitals in the U.S.
FIG. 38 Total number of in-patient surgeries in the U.S.,
FIG. 39 U.S. artificial ventilation and anesthesia masks market, high-risk procedures, 2012 - 2022 (USD Million)
FIG. 40 U.S. artificial ventilation and anesthesia masks market, moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 41 U.S. artificial ventilation and anesthesia masks market, standard patient, 2012 - 2022 (USD Million)
FIG. 42 Canada top five reasons for in-patient hospitalization, 2013
FIG. 43 Top five reasons for in-patient surgeries in Canada, 2013
FIG. 44 Canada artificial ventilation and anesthesia masks market, high-risk procedures, 2012 - 2022 (USD Million)
FIG. 45 Canada artificial ventilation and anesthesia masks market, moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 46 Canada artificial ventilation and anesthesia masks market, standard patient, 2012 - 2022 (USD Million)
FIG. 47 Number of people with COPD in the top five European countries, 2013 (million)
FIG. 48 Europe artificial ventilation and anesthesia masks market, high-risk procedures, 2012 - 2022 (USD Million)
FIG. 49 Europe artificial ventilation and anesthesia masks market, moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 50 Europe artificial ventilation and anesthesia masks market, standard patient, 2012 - 2022 (USD Million)
FIG. 51 Germany artificial ventilation and anesthesia masks market, high-risk procedures, 2012 - 2022 (USD Million)
FIG. 52 Germany artificial ventilation and anesthesia masks market, moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 53 Germany artificial ventilation and anesthesia masks market, standard patient, 2012 - 2022 (USD Million)
FIG. 54 UK artificial ventilation and anesthesia masks market, high-risk procedures, 2012 - 2022 (USD Million)
FIG. 55 UK artificial ventilation and anesthesia masks market, moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 56 UK artificial ventilation and anesthesia masks market, moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 57 Asia Pacific artificial ventilation and anesthesia masks market, moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 58 Asia Pacific artificial ventilation and anesthesia masks market, standard patients, 2012 - 2022 (USD Million)
FIG. 59 China artificial ventilation and anesthesia masks market, high-risk procedures, 2012 - 2022 (USD Million)
FIG. 60 China artificial ventilation and anesthesia masks market, moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 61 India artificial ventilation and anesthesia masks market, standard patients, 2012 - 2022 (USD Million)
FIG. 62 India artificial ventilation and anesthesia masks market, high-risk procedures, 2012 - 2022 (USD Million)
FIG. 63 RoW artificial ventilation and anesthesia masks market, moderate risk procedures, 2012 - 2022 (USD Million)
FIG. 64 RoW artificial ventilation and anesthesia masks market, standard patients, 2012 - 2022 (USD Million)
FIG. 65 Brazil artificial ventilation and anesthesia masks market, standard patients, 2012 - 2022 (USD Million)
FIG. 66 Brazil artificial ventilation and anesthesia masks market, standard patients, 2012 - 2022 (USD Million)
FIG. 67 South Africa artificial ventilation and anesthesia masks market, standard patients, 2012 - 2022 (USD Million)
FIG. 68 South Africa artificial ventilation and anesthesia masks market, standard patients, 2012 - 2022 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon